Cardiac resynchronization therapy in diabetic patients improves survival in the group of patients with atrial fibrillation in the first twelve years. Long term follow-up.

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Clinical Clinical EHRA Premium Access EHRA 2019

ESC 365 is supported by

ESC 365 is supported by